Effect of amlodipine on the pharmacokinetics of tacrolimus in rats

被引:12
作者
Zhou, Ya-nan [1 ,2 ]
Zhang, Bi-kui [1 ,2 ]
Li, Jing [1 ,3 ]
Zuo, Xiao-cong [1 ,2 ]
Yuan, Hong [1 ,2 ]
Yang, Guo-ping [1 ,2 ]
Cheng, Ze-neng [2 ]
Liu, Zhi [2 ]
Li, Pei-jiong [2 ]
Tan, Hong-yi [1 ]
Zhou, Ling-yun [1 ]
Wang, Chung-jiang [1 ]
Yang, Meng [1 ,2 ]
机构
[1] Cent S Univ, Clin Pharm & Pharmacol Res Inst, Xiangya Hosp 3, Changsha, Hunan, Peoples R China
[2] Cent S Univ, Sch Pharmaceut Sci, Changsha, Hunan, Peoples R China
[3] Hunan Childrens Hosp, Dept Pharm, Changsha, Hunan, Peoples R China
基金
中国国家自然科学基金; 国家教育部博士点专项基金资助;
关键词
Amlodipine; CYP3A2; drug-drug interaction; P-glycoprotein; pharmacokinetics; tacrolimus; P-GLYCOPROTEIN; GRAPEFRUIT JUICE; CLINICAL PHARMACOKINETICS; CYTOCHROME-P450; 3A; METABOLISM; TRANSPORT; POLYMORPHISMS; HYPERTENSION; INHIBITION; DILTIAZEM;
D O I
10.3109/00498254.2012.756992
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The immunosuppressant tacrolimus (TAC) is a substrate of cytochrome P450 3A2 (CYP3A2) and P-glycoprotein (P-gp) in rats. Amlodipine (AML) is an inhibitor of CYP3A2 in rats. We investigated the effect of AML on the pharmacokinetics of TAC in rats. 2. When co-administered with TAC orally or intravenously, AML decreased the oral clearance and raised the blood concentration of TAC in rats, but the T-1/2 of TAC was not significantly affected by AML. Upon oral administration of TAC, the effect of 15 mg/kg of AML on the AUC of TAC was lower than that seen with 5 or 10 mg/kg. However, upon intravenous TAC administration, the effect of 15 mg/kg of AML on the AUC of TAC was higher than that seen with 5 mg/kg. 3. AML is an inhibitor of P-gp and CYP3A2 in rats. If AML and TAC are co-administered orally, AML elicits greater inhibition in P-gp than CYP3A2 during first-pass metabolism. If AML is given orally and TAC given intravenously concurrently, AML mainly inhibits CYP3A2 activity and increases the blood concentration of TAC. There are significant pharmacokinetic interactions between TAC and AML. AML raises the blood concentration of TAC in rats probably by inhibiting P-gp and CYP3A2.
引用
收藏
页码:699 / 704
页数:6
相关论文
共 31 条
  • [1] Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery
    Benet, LZ
    Izumi, T
    Zhang, YC
    Silverman, JA
    Wacher, VJ
    [J]. JOURNAL OF CONTROLLED RELEASE, 1999, 62 (1-2) : 25 - 31
  • [2] Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man
    Bogaards, JJP
    Bertrand, M
    Jackson, P
    Oudshoorn, MJ
    Weaver, RJ
    van Bladeren, PJ
    Walther, B
    [J]. XENOBIOTICA, 2000, 30 (12) : 1131 - 1152
  • [3] Desjardins JP, 1995, J PHARMACOL EXP THER, V275, P1608
  • [4] Amlodipine inhibits rat microsomal cytochrome P450-mediated drug biotransformation
    Drobitch, RK
    McLellan, RA
    Renton, KW
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (12) : 1501 - 1503
  • [5] First MR, 2004, J NEPHROL, V17, pS25
  • [6] Effects of intestinal and hepatic metabolism on the bioavailability of tacrolimus in rats
    Hashimoto, Y
    Sasa, H
    Shimomura, M
    Inui, K
    [J]. PHARMACEUTICAL RESEARCH, 1998, 15 (10) : 1609 - 1613
  • [7] Interaction between tacrolimus and intravenous nicardipine in the treatment of post-kidney transplant hypertension at pediatric hospitals
    Hooper, David K.
    Carle, Adam C.
    Schuchter, Joseph
    Goebel, Jens
    [J]. PEDIATRIC TRANSPLANTATION, 2011, 15 (01) : 88 - 95
  • [8] Hutchinson IV, 1997, NEW HORIZONS KIDNEY, V1, P22
  • [9] IMAOKA S, 1990, J PHARMACOL EXP THER, V255, P1385
  • [10] Effect of grapefruit juice on the pharmacokinetics of amlodipine in healthy volunteers
    Josefsson, M
    Zackrisson, AL
    Ahlner, J
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 51 (02) : 189 - 193